«Zollinger-Ellison

Below is an extended Zollinger-Ellison patents listing. Click here to return to the Zollinger-Ellison main in depth entry.

Patents :
US Patent No.	Title
7238660	Albumin fusion proteins
7297503	Methods of identifying reduced internalization transmembrane receptor agonists
7297816	Sulfonamide compounds
7301006	Methods and materials for the synthesis of modified peptides
7304051	Quinoxaline compounds
7307152	Secreted and transmembrane polypeptides and nucleic acids encoding the same
7312304	Somatostatin agonists
7317092	Secreted and transmembrane polypeptides and nucleic acids encoding the same
7326718	8-Substituted imidazopyridines
7326724	Salts of omeprazole and esomeprazole I
7332292	Constitutively translocating cell line
7288651	Preparation of quinoxaline compounds
7285668	Process for the crystallization of (R)- or (S)-lansoprazole
7279324	Nucleic acid encoding G-protein coupled receptor with modified DRY motif
7238667	Albumin fusion proteins
7238695	Imidazolyl derivatives
7238814	Compositions of S-nitrosothiols and methods of use
7241759	Benzo[1,2,5]thiadiazole compounds
7241865	Secreted and transmembrane polypeptides and nucleic acids encoding the same
7244753	Cyclooxygenase-2 selective inhibitors, compositions and methods of use
7256205	Nitrosated and nitrosylated H.sub.2 receptor antagonist compounds, compositions and methods of use
7271146	Methods for treatment of Helicobacter pylori-associated disorders
7271182	Salts of benzimidazole compound and use thereof
7276354	Polynucleotides encoding a novel human G-protein coupled receptor splice variant, HGPRBMY29SV2
7332505	Nitrosated and nitrosylated proton pump inhibitors, compositions and methods of use
7332517	Derivatives of hydantoins, thiohydantoins, pyrimidinediones and thioxopyrimidinones, their preparation processes and their use as medicaments
7385036	Human tango 509 polypeptides
7390879	Secreted and transmembrane polypeptides and nucleic acids encoding the same
7393861	Derivatives of 4-aminopiperidine and their use as a medicament
7396841	Injections
7399485	Rapidly Disintegrable solid preparation
7402403	Tumour markers
7408024	Somatostatin antagonists
7408038	Secreted immunomodulatory proteins
7410981	Prodrugs of imidazole derivatives, for use as proton pump inhibitors in the treatment of e.g. peptic ulcers
7411051	Antibodies to HDPPA04 polypeptide
7384561	Apparatus and method for separating magnetic particles
7381800	Antibodies to HBIMF63 polypeptide
7378507	PRO217 polypeptides
7338781	Organic anion transporting (oat)-like protein UST3-LIKE1 and uses thereof
7339064	Benzimidazole compound crystal
7345061	Alkylammonium salts of omeprazole and esomeprazole
7345148	Human G-protein coupled receptor, HGPRBMY29sv1 polypeptides
7348140	Clinical indications for genotyping polymorphic variants of G-protein coupled receptors
7355002	Secreted and transmembrane polypeptides and nucleic acids encoding the same
7365047	Use of pentagastrin to inhibit gastric acid secretion or as a diuretic
7368527	HADDE71 polypeptides
7368531	Human secreted proteins
7378488	Somatostatin antagonists
7411070	Form of S-omeprazole

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.  See User Agreement

Send comments and feedback to:
Peter Barfoot Managing Director, BioPortfolio Ltd.
UK Tel: (+44) 1300 321501
USA Voicemail and Fax: (+1) 415 680 2472

All rights reserved. All other trademarks recognized.

BioPortfolio Limited is registered in England & Wales at Wessex Barn, Dorchester Road, Frampton, Dorset, DT2 9NB, UK. No.3312883 VAT No. GB 744 6483 10

Copyright 1997-2008 - BioPortfolio Limited.